Growth Metrics

Oculis Holding AG (OCS) Current Assets (2021 - 2026)

Quarterly Current Assets rose 38.07% to $289.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $289.9 million through Mar 2026, up 38.07% year-over-year, with the annual reading at $273.9 million for FY2025, 128.71% up from the prior year.

Oculis Holding AG's Current Assets history spans 6 years, with the latest figure at $289.9 million for Q1 2026.

  • Current Assets came in at $289.9 million for Q1 2026, up from $273.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $289.9 million in Q1 2026 to a low of $24.6 million in Q4 2022.
  • The 5-year median for Current Assets is $135.0 million (2023), against an average of $157.8 million.
  • Year-over-year, Current Assets plummeted 52.81% in 2022 and then skyrocketed 363.75% in 2023.
  • Oculis Holding AG's Current Assets stood at $24.6 million in 2022, then soared by 363.75% to $113.9 million in 2023, then increased by 5.15% to $119.7 million in 2024, then soared by 128.71% to $273.9 million in 2025, then rose by 5.86% to $289.9 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Current Assets are $289.9 million (Q1 2026), $273.9 million (Q4 2025), and $188.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 10.37 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.31 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 73.04 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 11.73 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 18.21 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.22 Bn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 289.93 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 289.93 Mn
Dec 31, 2025 273.87 Mn
Sep 30, 2025 188.65 Mn
Jun 30, 2025 200.75 Mn
Mar 31, 2025 209.98 Mn
Dec 31, 2024 119.74 Mn
Sep 30, 2024 128.68 Mn
Jun 30, 2024 137.82 Mn
Mar 31, 2024 97.89 Mn
Dec 31, 2023 113.88 Mn
Sep 30, 2023 130.76 Mn
Jun 30, 2023 134.98 Mn
Dec 31, 2022 24.56 Mn
Dec 31, 2021 52.04 Mn